Weight loss service in Tampa, FL
You have tried cutting calories and exercising harder. The scale still does not move. Tirzepatide works differently, targeting the hormonal signals that drive hunger and store fat, as part of a supervised plan built around your body.
You have tried cutting calories and exercising harder. The scale still does not move. Tirzepatide works differently, targeting the hormonal signals that drive hunger and store fat, as part of a supervised plan built around your body.
Explore more in our weight loss service services .
More patient stories are coming soon. In the meantime, read our verified reviews on Google or ask our team for references at your consultation.
Tirzepatide activates both the GLP-1 and GIP hormone receptors, while semaglutide targets GLP-1 alone. The dual-action mechanism suppresses appetite through two pathways simultaneously and improves insulin sensitivity more broadly. Head-to-head trial data published in the New England Journal of Medicine showed meaningfully greater average weight loss with tirzepatide at equivalent treatment duration. Your provider will confirm which medication matches your metabolic profile.
Most patients report a noticeable reduction in hunger and fewer cravings within the first two to four weeks at the starting dose. Scale movement typically follows by weeks six to eight as caloric intake decreases and metabolic improvements compound. Progress varies based on starting hormone levels, diet adherence, and the dose titration schedule your provider sets.
Yes, in most cases. AgeRejuvenation routinely combines tirzepatide with hormone optimization for patients where labs show both metabolic dysfunction and a hormonal driver of weight gain. Managing both issues together typically produces faster and more durable results than addressing either alone. Your provider will review your full panel before combining treatments.
Coverage varies. Tirzepatide is FDA-approved for type 2 diabetes under the brand Mounjaro; its weight-loss indication under Zepbound has broader but still inconsistent insurance coverage. Our team will verify your benefits before prescribing and will discuss compounding or financing options if coverage is limited. Medication cost should not be the reason you do not start treatment.
Weight regain is a risk when any GLP-1/GIP medication is discontinued without a maintenance plan in place. AgeRejuvenation builds the transition into your program from day one: nutrition habits, hormone optimization if indicated, and a structured taper schedule are all designed so your results are not entirely dependent on the medication continuing indefinitely. Many patients successfully transition to a lower maintenance dose or move to a different support protocol.
Speak with a care coordinator at the location nearest you.
